Bruno Cassiman and Don O’Sullivan presented several months back on R&D strategy and executive compensation, respectively. Bruno’s talk was on how collaboration on research and development (through open innovation and science linkages) can dramatically affect R&D outcomes. Don spoke on how the structure of executive compensation relates to the valuation of intangible assets.
Thanks to each speaker for allowing us to share their presentations online.
Last week MBS hosted a public seminar on “Who Owns the News?” exploring the impact of the internet on the news industry. The event was organized by IPRIA, CMCL and MBS CITE. It serves to clarify the key issues and lays the groundwork for a discussion of these issues. I had fun and hope that the 110+ people who attended it did too.
Sam Ricketson, Professor at Melbourne Law School, chaired the event and did a great job orchestrating the Q&A session. Mark Davison from Monash spoke about changes in copyright law and expressed concerns over the “Hot News” doctrine, an approach currently being proposed by news organizations in the US to prevent others from copying their content. Stephen King outlined the economic issues and has posted his very thoughtful comments at https://economics.com.au/?p=5909.
As the discussant, I described what I had learnt from Mark and Stephen and also tried to consider various options faced by a CEO in this industry. My pdf slides are at http://works.bepress.com/kwanghui/18. While my comments might have been perceived as pessimistic by Stephen and others, I am actually quite optimistic about the future of the industry, but mainly for individuals and firms trying out innovative ways of gathering and delivering the news. I am however pessimistic about existing firms: if history has taught us anything, it is that many of them will struggle to adapt with these drastic changes.
The video recordings for “Who Owns the News?” are now available. I have posted them at http://vimeo.com/album/253549. Portions were removed to protect the identity of audience members. We thank the speakers for permission to share their insights online. Enjoy the show 😉
Last year David Weston and I wrote a teaching case on how in 2000, NTP sued Research in Motion (makers of the popular BlackBerry device) for infringing its patents that cover the wireless delivery of email (free download from WIPO). Well, NTP is at it again, and has just sued a number of firms including Apple, Google, LG, Motorola, HTC and Microsoft that make smartphones. The Washington Post has a brief description of the patents. The earlier case ended with a $600+ million settlement, but that large amount was partly the result of (a) RIM was found to have willfully infringed NTP’s patents and attempted to deceive the court when presenting evidence of “prior art” in 2002, and (b) as the case escalated, RIM faced the very real threat of having its US operations closed down in 2005. A number of the original patent claims were subsequently revoked, but I imagine that NTP is hoping that the larger base of email users these days will give it enough licensing revenue from each of the mobile operators. If you haven’t heard of NTP, that is because the company is sometimes thought of as a patent troll and is not well-loved. In my opinion, the lawsuit also highlights a more subtle problem with the patent system. When successful firms like RIM and Nokia choose to settle with companies like NTP, it gives NTP an incentive and the financial resources to then attack a broader group of other firms. A precedence is also set. It would be better if such firms fought back, e.g., by establishing prior art that invalidates such patents or by pushing back on the claims.
Should Genes be Patented? This is a question of tremendous importance, and one that is the subject of an Australian Senate Inquiry. Chris Dent and I sent in a submission on behalf of IPRIA and CITE, which is available here. We believe there is insufficient empirical evidence (yet) upon which to make specific changes to patent law. Other people have quite different views, as expressed in their submissions. Next month, we are organizing a CITE & IRIA public event on this topic. It will include a discussion by four panelists: Gillian Mitchell of the PeterMac Cancer Centre, Gregory Mandel from Temple University, Dianne Nicol from the University of Tasmania, and Dan Peled from Haifa University in Israel. The event will be chaired and moderated by Joshua, and will include a 45-minute public debate. Post your thoughts here. Or better still, sign up for the event at http://www.ipria.org/events/seminar/Patenting%20Genes.html